Document is current
Any future updates will be listed below
-
Authors
Swain, Anshuman
Soni, Narayan Datt
Gaspar, Ryan B.
Davis, James G.
Liu, Fang
Juul, Halvor
Nanga, Ravi Prakash Reddy
Baur, Joseph A.
Reddy, Ravinder
-
Funding
Funding for this research was provided by:
National Institute of Diabetes and Digestive and Kidney Diseases (R01 DK098656)
National Institute on Aging (R01 AG063869)
National Institute of Biomedical Imaging and Bioengineering (P41 EB029460)
- License Information
-
More Information
Article History
Received: 15 September 2025
Accepted: 7 January 2026
First Online: 30 January 2026
Declarations
:
: All animal experiments were carried out using a protocol approved by the Institutional Animal Use & Care committee at the University of Pennsylvania.
: Not applicable.
: Joseph Baur reports receiving research funding and materials from Pfizer, Elysium Health and Metro International Biotech and consulting fees from Pfizer, Elysium Health, Altimmune, and Cytokinetics; he holds a patent for using NAD+ precursors in liver injury.
